Olympus AU680 analyser now offers fully automated HbA1c assay

1 Jun 2008

Product news

A fully automated HbA1c assay has now been introduced for the Olympus AU680 chemistry analyser. This new assay completely eliminates the inconvenience and risk associated with manual pre-treatment for this routinely used blood glucose monitoring test. With high-speed whole blood testing capability, laboratory professionals can attain even faster results and improved efficiencies with the AU680.

The introduction of complete HbA1c testing allows consolidation onto the recently introduced Olympus AU680 analyser, making it not only cost-effective but also able to streamline workflow with faster repeat and reflex testing. Optimised to meet the latest performance and standardisation requirements, the addition of the new HbA1c assay enables the AU680 system to deliver outstanding, fully automated performance for diabetes monitoring.

With fully automated HbA1c testing, the AU680 offers the ability to run diabetic clinics on a single platform. “By putting the HbA1c's on the main “work horse” analyser platform, they can be performed at the same time as other routine tests on diabetics are run,” explains Dr. Peter Szillat, Commercial Marketing Manager, Immunodiagnostics: “Therefore the 'whole' package of results is ready at the same time for the clinic or clinician, meaning less delay in return of results for the patient.”

With increased on-board reagents (up to 63 tests), reduced sample volumes, user-defined functions and flexible operation capabilities, combined with the recognised Olympus AU series’ standardisation and reliability, laboratories can utilise technician time effectively whilst benefiting from a cost-efficient system. In the future, the open analyser design of the AU680 will offer the advantage of direct sampling to third party track systems.

Capable of performing up to 1200 tests per hour the AU680 covers Olympus’ broad 125-test menu that includes general chemistries, ISEs, special chemistries, TDMs and DATs. The system also accommodates paediatric sampling and can perform automated pre-dilution and immediate STAT processing without workload interruption.

Links

Tags

Blood TransfusionBlood Transfusion involves giving donor blood to a recipient patient. Screening is essential to avoid transfusion reactions. Blood banks use immunohematological techniques to determine rh and ABO blood group, and screen for antibodies using specific antisera. Blood Banks use Direct Coombs Tests (DCT) and Indirect Coombs Tests (IAT) to detect hemolysis and Haemolytic Disease of the Newborn (HDN).HematologyIn Haematology / Hematology, complete blood cell counts (or full blood counts) are obtained using automated blood count analyzers to enumerate blood cell types.  Hematology also encompasses haemostasis and coagulation, thrombophilia and hemophilia, plasma viscosity and ESR analysis, hemoglobinopathies, cell morphology and haematinic measurement.Point-of-CarePoint-of-Care Testing (POCT) or Near Patient Testing (NPT) products are available for urine, blood and other clinical chemistry analyses. POCT includes: blood glucose testing, blood gas and electrolytes analysis, rapid coagulation testing (PT / INR), rapid cardiac markers diagnostics, drugs of abuse screening, urine strips testing, pregnancy testing, fecal occult blood analysis, food pathogens screening, hemoglobin diagnostics, infectious disease testing and cholesterol screening.Clinical TrialsClinical Trials, an essential part of drug discovery process, assess the safety and effectiveness of a new medication or device in the pharmaceutical industry. Clinical Trials are a phased process (Phase 0, Phase I, Phase II, Phase III and Phase IV) which begins after initial preclinical testing.
Olympus AU680 analyser now offers fully automated HbA1c assay